深層腦部刺激器的全球市場:現狀分析、預測(2022年～2028年)

Global Deep Brain Stimulation Devices Market: Current Analysis and Forecast (2022-2028)

出版日期: 2023年01月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球深部腦刺激器的市場規模，預計在預測期間內達成約12％的顯著成長。還有神經疾病增加，尖端技術的採用，是深層腦部刺激器市場的重要的成長促進因素。

本報告提供全球深層腦部刺激器市場相關調查分析，各市場區隔、各地區的市場洞察，市場動態，市場趨勢，競爭情形，企業簡介等系統性資訊。

The global deep brain stimulation devices market is expected to grow at a significant rate of around 12% during the forecast period. Deep brain stimulation (DBS) involves the application of a device called a neurostimulator, to deliver electrical signals to the areas of the brain that control movement, pain, mood, weight, obsessive-compulsive thoughts, and awakening from a coma. The rising occurrence of neurological diseases, along with the adoption of advanced technology are the important factors responsible for the growth of the deep brain stimulation devices market. Furthermore, frequent product launches also attribute to the surging demand for deep brain stimulation devices. For instance, Medtronic plc, the global leader in medical technology announced the U.S. Food and Drug Administration (FDA) approval for its SenSight™ Directional Lead System, which is the first U.S. implant used for deep brain stimulation (DBS) therapy.

Abbott; Boston Scientific Corporation; Medtronic; Aleva Neurotherapeutics; Nexstim Oyj; LivaNova PLC; NeuroPace, Inc.; Functional Neuromodulation Ltd.; SceneRay Co., Ltd.; and Neuronetics. Are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Application, epilepsy category to witness higher CAGR during the forecast period"

Based on the application, the market has been categorized into pain management, epilepsy, essential tremor, obsessive-compulsive disorder (OCD), Parkinson's disease, depression, dystonia, and others. Among them, the epilepsy segment is expected to grow at the highest CAGR in the market. The rising prevalence of epilepsy and the growing awareness about advanced treatment options are the important factors responsible for the segmental growth. For instance, according to WHO, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

"Amongst End-use, ambulatory surgical centers segment to grow with a significant CAGR during the forecast period"

Based on the end-use, the market has been categorized into hospitals, neurology clinics, ambulatory surgical centers, and research centers. Among them, the ambulatory surgical center's segment is expected to grow at a significant CAGR during the forecast period. The ASCs provide the point of care treatment, can offer low-cost treatment, and reduces waiting time in emergency cases. These factors are responsible for the segmental growth of ambulatory surgical centers.

"Asia Pacific to witness the fastest growth in the market"

For a better understanding of the market adoption of the deep brain stimulation devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. The major factors such as rising medical expenditure, increasing disposable income of people, along with favorable government initiatives attributes to the market growth of deep brain stimulation devices in the region. For instance, as per the world bank, the per capita healthcare expenditure of Japan accounted for USD 3988.36 in 2012, which reached USD 4587.03 in 2019.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global Deep Brain Stimulation Devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1. MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Deep Brain Stimulation Devices Market
2.2. Research Methodology of the Deep Brain Stimulation Devices Market
2.3. Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE DEEP BRAIN STIMULATION DEVICES MARKET

6. DEEP BRAIN STIMULATION DEVICES MARKET REVENUE (USD BN), 2020-2028F

7. MARKET INSIGHTS BY APPLICATION

7.1. Pain management
7.2. Epilepsy
7.3. Essential tremor
7.4. Obsessive-compulsive disorder (OCD)
7.5. Parkinson's disease
7.6. Depression
7.7. Dystonia
7.8. Others

8. MARKET INSIGHTS BY END-USE

8.1. Hospitals
8.2. Neurology clinics
8.3. Ambulatory surgical centers
8.4. Research centers

9. MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World